Literature DB >> 32022675

Alpha-1 adrenergic antagonists use increases the risk of sleep apnea: implications for understanding the role of prazosin in posttraumatic stress syndrome.

William V McCall1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32022675      PMCID： PMC7161435          DOI： 10.5664/jcsm.8296

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  6 in total

Review 1.  Posttraumatic stress disorder and sleep-disordered breathing: a review of comorbidity research.

Authors:  Barry J Krakow; Victor A Ulibarri; Bret A Moore; Natalia D McIver
Journal:  Sleep Med Rev       Date:  2014-11-21       Impact factor: 11.609

2.  Alpha-1 Adrenergic-Antagonist Use Increases the Risk of Sleep Apnea: A Nationwide Population-Based Cohort Study.

Authors:  Po-Lan Su; Wen-Kuei Lin; Cheng-Yu Lin; Sheng-Hsiang Lin
Journal:  J Clin Sleep Med       Date:  2019-11-15       Impact factor: 4.062

3.  Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.

Authors:  Murray A Raskind; Elaine R Peskind; Bruce Chow; Crystal Harris; Anne Davis-Karim; Hollie A Holmes; Kimberly L Hart; Miles McFall; Thomas A Mellman; Christopher Reist; Jennifer Romesser; Robert Rosenheck; Mei-Chiung Shih; Murray B Stein; Robert Swift; Theresa Gleason; Ying Lu; Grant D Huang
Journal:  N Engl J Med       Date:  2018-02-08       Impact factor: 91.245

4.  A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.

Authors:  Murray A Raskind; Kris Peterson; Tammy Williams; David J Hoff; Kimberly Hart; Hollie Holmes; Dallas Homas; Jeffrey Hill; Colin Daniels; Jess Calohan; Steven P Millard; Kirsten Rohde; James O'Connell; Denise Pritzl; Kevin Feiszli; Eric C Petrie; Christopher Gross; Cynthia L Mayer; Michael C Freed; Charles Engel; Elaine R Peskind
Journal:  Am J Psychiatry       Date:  2013-09       Impact factor: 18.112

5.  Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder.

Authors:  Kirsten C George; Lisa Kebejian; Leigh J Ruth; Christopher W T Miller; Seth Himelhoch
Journal:  J Trauma Dissociation       Date:  2016-02-02

6.  A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares.

Authors:  William Vaughn McCall; Anilkumar Pillai; Doug Case; Laryssa McCloud; Tiffany Nolla; Fallon Branch; Nagy A Youssef; Jason Moraczewski; Liniya Tauhidul; Chirayu D Pandya; Peter B Rosenquist
Journal:  J Clin Psychopharmacol       Date:  2018-12       Impact factor: 3.153
  6 in total
  1 in total

Review 1.  The Many Faces of Sleep Disorders in Post-Traumatic Stress Disorder: An Update on Clinical Features and Treatment.

Authors:  Franziska C Weber; Thomas C Wetter
Journal:  Neuropsychobiology       Date:  2021-09-02       Impact factor: 12.329
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.